Maintenance of immune memory to the hepatitis B envelope protein following adoptive transfer of immunity in bone marrow transplant recipients

Bone Marrow Transplantation

Volumn 26, Issue 6, 2000, Pages 633-638

  Ilan, Y ^a   Nagler, A ^a   Zeira, E ^a   Adler, R ^a   Slavin, S ^a   Shouval, D ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

Adoptive transfer of immunity; Bone marrow transplantation; Hepatitis B virus; Long term

Indexed keywords

CARMUSTINE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; CYTARABINE; ETOPOSIDE; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; HLA ANTIBODY; MELPHALAN; METHOTREXATE; THIOTEPA; VIRUS ENVELOPE PROTEIN;

ACTIVE IMMUNIZATION; ADOPTIVE TRANSFER; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; BONE MARROW CELL; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; DONOR; FOLLOW UP; HEPATITIS B; HEPATITIS B VIRUS; HLA MATCHING; HUMAN; IMMUNOLOGICAL MEMORY; IN VITRO STUDY; LYMPHOCYTE ACTIVATION; PASSIVE IMMUNIZATION; PERIPHERAL LYMPHOCYTE; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECIPIENT; SEROCONVERSION; TREATMENT OUTCOME;

EID: 0033799470     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1702571     Document Type: Article

References (41)

1. The epidemiology of viral hepatitis in the United States
2. Hepatitis B: Evolving epidemiology and implications for control
3. Hepatitis B virus immunopathogenesis
4. Persistence of hepatitis B viral DNA after serological recovery from hepatitis B virus infection
5. Persistent infection of humans with hepatitis B virus: Mechanisms and consequences
6. Fulminant hepatitis due to reactivation of chronic hepatitis B virus infection after allogeneic bone marrow transplantation
7. Hepatitis viruses and hematopoietic cell transplantation: A guide to patient and donor management
8. The kinetics of immune reconsititution after allogeneic human marrow transplantation
9. Allogeneic bone marrow transplantation from HbsAg+ donors: A multicenter study from the Gruppo Italiano Trapianto di Midolol Osseo (GITMO)
10. Recovery of antibody production in human allogeneic marrow graft recipients: Influence of time post transplantation, the presence or absence of chronic graft versus host disease, and anti-thymocyte globulin treatment
11. Immunization against hepatitis B in BMT and leukemia patient
12. Pneumoccocal vaccination of recipients of bone marrow transplants
13. Immunity against Pseudomonas aeruginosa transferred to bone marrow transplants recipients
14. Designed transfer of specific immune responses with bone marrow transplantation
15. A transfer of functioning humoral immune system in transplantation of T lymphocytic depleted bone marrow
16. Adoptive T cell therapy of tumors: Mechanisms operative in the recognition and elimination of tumor cells
17. Principles for adoptive T cell therapy of human viral disease
18. Restoration of viral immunity in immunodeficient humans by adoptive transfer of T cell clones
19. Reconsititution of cellular immunity against CMV in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor
20. Adoptive transfer of immunity to hepatitis B virus in mice by bone marrow transplantation from HBV immune donors
21. Adoptive transfer of immunity to hepatitis B: Development of the concept and evolution of the research project for targeted immunotherapy against hepatic cells which express a viral antigen
22. Cytotoxic T-lymphocytes response to cytomegalovirus after human allogeneic bone marrow transplantation: Pattern of recovery and correlation with CMV infection and disease
23. Recovery of HLA-restricted cytomegalovirus-specific T cell response after allogeneic bone marrow transplant: Correlation with CMV disease and effect of gancyclovir prophylaxis
24. Identification of target antigens for the human cytotoxic T cell response to Epstein Barr virus: Implications for the immune control of EBV positive malignancies
25. Localization of Epstein Barr virus cytotoxic T cell epitopes using recombinant vaccinia. Implication for vaccine development
26. Inhibition of antigen processing by the internal repeat region of the EBV nuclear antigen-1
27. Infusions of donor leukocytes to treat EBV-associated lymphoproliferative disorders after allogeneic bone marrow transplantation
28. Limiting-dilution analysis of the HLA restriction of anti-EBV specific cytolytic T lymphocytes
29. Adoptive cellular immunotherapy for EBV lymphopoliferative disease
30. Adoptive cell therapy with donor lymphocytes for EBV-associated lymphomas developing after allogeneic marrow transplants
31. Clearance of persistent hepatitis B virus infection in Chinese bone marrow transplant recipients whose donors were anti-hepatitis B core and anti-hepatitis B surface antibody-positive
32. Clearance of hepatitis B surface antigen after bone marrow transplantation: Role of adoptive immunity transfer
33. Adoptive transfer of immunity to hepatitis B in humans following T-depleted bone marrow transplantation from HBV immune donors
34. Development of antibodies to hepatitis B virus surface antigen in bone marrow transplant recipient following treatment with peripheral blood lymphocytes from immunized donors
35. Transplantation of hepatitis B immune lymphocytes as means for adoptive transfer of immunity to HBV
36. Ablation of persistent hepatitis B by allogeneic bone marrow transplantation from an HBV immune donor
37. Improved double antibody radioimmunoassay (RIA-DA) methodology for detecting hepatitis B antigen and antibody
38. Cytotoxic T Lymphocyte responsiveness after resolution of chronic hepatitis B virus infection
39. Cytotoxic T cells and viral hepatitis
40. Is vaccination of donor adequate for clearance of hepatitis B virus after bone marrow transplantation?
41. Suppression of human hepatoma in mice through adoptive transfer of immunity to hepatitis B surface antigen